Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsHigher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.
Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.
Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.
1.
In a study, immune detection of oral cancers is linked to obesity.
2.
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer
3.
Is Laughter Good for Blood Glucose Control?
4.
Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment
5.
GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer
1.
What You Need To Know About Secondary Polycythemia: Treatment & Symptoms
2.
Contemporary Approaches in Hematology for Specialists
3.
Understanding Lymphedema: Symptoms, Causes, and Treatment
4.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
5.
Understanding Iron Saturation Levels in Your Blood
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge